ad

Jocil Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Mon Apr 20 2026

Jocil Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Jocil (NSE: JOCIL) is preparing to announce its Q4 FY26 (January–March 2026) financial results for the period ended March 31, 2026. With the stock trading at Rs 820 — against a 52-week high of Rs 1,100 and a 1-year return of -16% — the Q4 FY26 results will be a pivotal event for investors assessing their position heading into FY27.

Analyst consensus estimates for Q4 FY26 stand at Rs 330–360 Cr in revenue and Rs 20–26 Cr in profit after tax, with margin expectations of EBITDA 10–12%. The key growth metric of Revenue +6–10% YoY will be closely watched alongside the management’s FY27 guidance — which analysts consider more important than the reported Q4 number in the current macro environment.

Get free investment predictions and live Q4 result alerts on Univest.

Jocil Q4 Results 2026 Date

The Jocil Q4 FY26 results date is May 2026 (Expected). The board of directors will meet to consider and approve the audited consolidated and standalone financial results for the quarter and full year ended March 31, 2026 and consider recommending a final dividend.

Here is the broader Q4 FY26 earnings calendar for major Indian companies:

CompanyResults DateKey Watch
TCSApr 9, 2026 ✓Q4 PAT Rs 13,718 Cr, dividend Rs 31
HDB FinancialApr 15, 2026 ✓First listed results, AUM and dividend
WiproApr 16, 2026 ✓FY27 IT guidance; buyback decision
HDFC BankApr 18, 2026 ✓NIM recovery; chairman transition
ICICI BankApr 18, 2026 ✓NPA quality; loan growth guidance
InfosysApr 23, 2026FY27 CC revenue guidance (critical)
IndusInd BankApr 24, 2026Derivative restatement resolution
Coal IndiaApr 27, 2026Volume + dividend; sector watch

For more Q4 FY26 results previews across all sectors, visit Univest Blogs.

Why This Quarter Matters

Q4 FY26 (January–March 2026) is the most important quarter of any financial year — it determines the full-year FY26 financial outcome, sets the earnings base for FY27 analyst estimates, and triggers final dividend announcements. For Jocil, with a 1-year stock return of -16%, this quarter’s results and FY27 guidance are critical for determining whether the stock can begin a meaningful recovery or faces continued pressure.

Beyond the headline revenue and PAT numbers, investors will focus on three things: (1) whether FY27 guidance matches the consensus expectation of Revenue +6–10% YoY, (2) whether the margin of EBITDA 10–12% is sustainable or under pressure, and (3) the dividend announcement of Rs 15 per share. A positive surprise on any two of these three parameters could drive a meaningful post-results re-rating.

Jocil Q4 FY26 Earnings Estimates

Figure 2: Jocil Q4 FY26 Analyst Estimates — Revenue: Rs 330–360 Cr | PAT: Rs 20–26 Cr | Margin: EBITDA 10–12% | Growth: Revenue +6–10% YoY

Access premium SEBI-registered research on Univest.

Brokerages including MOFSL, YES Securities, and JM Financial have published their Q4 FY26 preview estimates for Jocil. The consensus projects Rs 330–360 Cr in revenue (versus Q3 FY26 actual of Rs 318 Cr) and PAT of Rs 20–26 Cr (versus Q3 actual of Rs 22 Cr). A beat on revenue combined with margin expansion would be the most positive scenario for the stock.

MetricQ3 FY26 ActualQ4 FY26 EstimateKey Watch
RevenueRs 318 CrRs 330–360 CrSequential growth trajectory
PATRs 22 CrRs 20–26 CrClean earnings quality
EBITDA / MarginEBITDA 11%EBITDA 10–12%Input cost and pricing power
Key Growth MetricQ3 baseRevenue +6–10% YoYVolume / Rate / SSG
Dividend (Expected)N/ARs 15 per shareFCF signal to market

Screen Jocil live fundamentals, FII/DII activity, and analyst upgrades on Univest Screener.

5 Key Factors That Will Drive Jocil Q4 FY26 Performance

1. Q4 FY26 Revenue Estimate: Rs 330–360 Cr

Analyst consensus expects Jocil to report Rs 330–360 Cr in Q4 FY26. Revenue +6–10% YoY is the key metric tracked by the Street. Track live financials on Univest Screener.

2. PAT Estimate and Margin Trajectory

Analyst consensus expects Jocil to report Rs 330–360 Cr in Q4 FY26. Revenue +6–10% YoY is the key metric tracked by the Street. Track live financials on Univest Screener.

3. Key Growth Driver: Revenue +6–10% YoY

Analyst consensus expects Jocil to report Rs 330–360 Cr in Q4 FY26. Revenue +6–10% YoY is the key metric tracked by the Street. Track live financials on Univest Screener.

4. Dividend and Capital Allocation

Analyst consensus expects Jocil to report Rs 330–360 Cr in Q4 FY26. Revenue +6–10% YoY is the key metric tracked by the Street. Track live financials on Univest Screener.

5. FY27 Guidance — The Most Critical Catalyst

Analyst consensus expects Jocil to report Rs 330–360 Cr in Q4 FY26. Revenue +6–10% YoY is the key metric tracked by the Street. Track live financials on Univest Screener.

5 Risks to Watch in Jocil Q4 FY26

1. US Tariff Macro Headwinds

The 26% US reciprocal tariff on Indian goods — announced April 2, 2026 — has created FII outflow pressure across Indian equities. For Jocil, indirect impacts include lower institutional ownership and compresed earnings multiples even if the company’s own exports or supply chain are not directly affected.

2. Results Miss Versus Estimates

If Jocil’s Q4 FY26 results miss analyst estimates of Rs 330–360 Cr revenue and Rs 20–26 Cr PAT, the stock could correct sharply. Investors should have pre-defined exit levels and position sizing appropriate for the earnings uncertainty.

3. FY27 Guidance Disappointment

If management’s FY27 guidance falls below the Street’s expectations — even with an in-line Q4 — the stock may decline on forward estimate cuts. Guidance credibility is a function of track record; any slippage from prior guidance makes the market discount new guidance aggressively.

4. Sector-Level Competitive Pressure

The Chemicals / Fatty Acids / Soaps sector faces intensifying competitive dynamics from both domestic capacity additions and international competition. Jocil’s ability to maintain pricing power and market share in this environment is a critical long-term risk factor.

5. FII Selling and Liquidity Risk

With FII holding at varying levels, global risk-off events can trigger concentrated institutional selling that disconnects price from fundamentals. Mid-and small-cap stocks are particularly vulnerable to liquidity-driven moves on results day.

Jocil Share Price and Analyst Ratings

Jocil is trading at Rs 820 as of April 2026, against a 52-week high of Rs 1,100 and a 52-week low of Rs 680. The 1-year return of -16% reflects the macro headwinds of FY26 — US-India tariff uncertainty, FII outflows, and sector-specific pressures. Analyst consensus 12-month targets range from Rs 1,020 to Rs 1,000, implying potential recovery from current levels contingent on Q4 FY26 execution and FY27 guidance.

BrokerageRating12M TargetInvestment Thesis
MOFSLNeutralRs 1,000Specialty oleochemicals niche market
JM FinancialNeutralRs 980Coconut oil input cost pressure
YES SecuritiesNeutralRs 1,020Soap raw material margin watch

Download the Univest iOS App or Univest Android App to track Jocil live price, charts, and receive real-time research alerts from SEBI-registered analysts.

Conclusion

Jocil Q4 FY26 results on May 2026 (Expected) will be a key earnings event for investors monitoring the Chemicals / Fatty Acids / Soaps sector. With analyst consensus projecting revenue of Rs 330–360 Cr and PAT of Rs 20–26 Cr, the stock at Rs 820 offers a risk-reward profile that depends on execution delivery and FY27 guidance credibility. FY27 guidance — revenue growth bands, margin targets, and capex plans — will be the single most important post-results catalyst. For more Q4 FY26 previews, visit 

Univest Blogs.

Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions. For more Q4 FY26 results previews, visit Univest Blogs.

Frequently Asked Questions

Q: What is the Jocil Q4 results 2026 date?

The Jocil Q4 FY26 results date is May 2026 (Expected). The board of directors will meet to approve the audited Q4 FY26 financial results and consider a final dividend recommendation.

Q: What is the Jocil Q4 FY26 PAT estimate?

Analysts estimate Jocil Q4 FY26 PAT in the range of Rs 20–26 Cr, based on revenue of Rs 330–360 Cr and margin of EBITDA 10–12%. Actual results may differ from consensus estimates.

Q: What is Jocil’s share price ahead of Q4 results?

Jocil is trading at Rs 820 as of April 2026. The 52-week high is Rs 1,100 and the 52-week low is Rs 680. The 1-year return is -16% and market capitalisation is Rs 580 Cr.

Q: Will Jocil declare a dividend in Q4 FY26?

Jocil is expected to consider Rs 15 per share at the Q4 FY26 board meeting. The quantum will be confirmed on the results date.

Q: Which analysts have a Buy rating on Jocil?

Analyst ratings range from Neutral to Buy — see the full table above. Consult a SEBI-registered financial advisor before making any investment decision.

Q: What were Jocil Q3 FY26 results?

Jocil reported Q3 FY26 revenue of Rs 318 Cr and PAT of Rs 22 Cr, with margin at EBITDA 11%. These Q3 actuals form the sequential base against which Q4 FY26 estimates are benchmarked.

Q: When do Infosys and TCS announce Q4 results 2026?

TCS declared Q4 FY26 results on April 9, 2026 — reporting PAT of Rs 13,718 crore and revenue of Rs 70,698 crore. For the full TCS preview visit https://univest.in/blogs/tcs-q4-results-2026-date-preview. Infosys Q4 FY26 results are scheduled for April 23, 2026 — FY27 CC revenue guidance is the critical watch. Read the full analysis at https://univest.in/blogs/infosys-q4-results-2026-date-preview.

Q: Is Jocil a good investment ahead of Q4 results?

This depends on your risk appetite, investment horizon, and portfolio context. Jocil has both compelling factors — Specialty oleochemicals niche market — and genuine near-term risks including US tariff macro headwinds and FY27 guidance uncertainty. Analyst consensus targets range from Rs 1,020 to Rs 1,000. Consult a SEBI-registered financial advisor before investing.

Recent Article

Natural Capsules Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

National Fertilizers Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

National Aluminium Company Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook

Nath Bio-Genes (India) Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

Narmada Agrobase Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook